![]() Cell Tissue Technology Cell Tissue Technology is a biotech company specializing in tissue engineering, regenerative medicine, and cellular therapy. | ![]() The Biomedical Engineering Society The Biomedical Engineering Society (BMES) is a non-profit biomedical research and development organization. | ![]() Vita 34 Vita 34 is the largest and the most experienced umbilical cord blood bank for medical precaution by means of stem cells in the German-speaking countries. | ||
Founding Date | Founding Date 2010 | Founding Date 1968 | Founding Date 1990 | Founding Date 1997 |
Type | Type Private | Type Private | Type Public | Type Public |
Tags | ||||
Locations | Locations Seri Kembangan, MY HQ Seri Kembangan, MY | Locations Landover, US HQ | Locations Stockholm, SE HQ Hiroshima Shi, JP Minato Ku, JP Singapore, SG Lund, SE Doral, US | Locations Leipzig, DE HQ Leipzig, DE |
Employees | Employees 19 | Employees 6282% decrease | Employees 167 | Employees 771 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 1 b | Valuation ($) 77.9 m |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $3m (FY, 2021) | Revenue (est.) kr1.5b (FY, 2025) | Revenue (est.) €88.2m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods kr391m (FY, 2025) | Cost of goods €30m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit kr1.1b (FY, 2025) | Gross profit €59.8m (FY, 2025) |
Net income | Net income N/A | Net income $210.3k (FY, 2021) | Net income kr332.8m (FY, 2025) | Net income (€5m) (FY, 2025) |

The Biomedical Engineering Society (BMES) is a non-profit biomedical research and development organization.
View company
BioGaia is a biotechnology company that develops and sells probiotic solutions.
View company
Vita 34 is the largest and the most experienced umbilical cord blood bank for medical precaution by means of stem cells in the German-speaking countries.
View company